NOUVEAU LIFE PHARMS INC by Nouveau Life Pharmaceuticals, Inc. (NOUV) Stock Price, Quote, News & History

NOUVOTCEM

Trade with Public

$0.000001

At close: Jun 12, 5:00 PM EST

OverviewNews Short Interest

Key Statistics

Open

Volume / Avg.

0 / 1.20M

Day Range

- - -

52 Wk Range

0.00 - 0.00

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Nouveau Life Pharmaceuticals Inc News

The Week Ahead In Cannabis: KushCo Earnings, House Panel's Historic Hearing And More

Alex Oleinic

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-21.52K

Investing Cash Flow (TTM)

-1.18K

Financing Cash Flow (TTM)

16.33K

Free Cash Flow (TTM)

-22.70K

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-6.37K

Valuation Metrics

Enterprise Value

$666.10K

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

Company Debt

Total Debt

$64.54K

LT Debt

$4.79K

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$347.00

Debt to Equity

1.51

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

0 / 1.20M

Day Range

- - -

52 Wk Range

0.00 - 0.00

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Pharmaceuticals

Nouveau Life Pharmaceuticals Inc is a healthcare solution company that provides non-face-to-face care services. Its product portfolio includes SILBY, Tomy, Amy, Maro, and Kiromy.

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy NOUVEAU LIFE PHARMS INC by Nouveau Life Pharmaceuticals, Inc. (NOUV) stock?

You can purchase shares of NOUVEAU LIFE PHARMS INC by Nouveau Life Pharmaceuticals, Inc. (OTCEM:NOUV) through any online brokerage.

View our list of the best stock brokerages

Who are NOUVEAU LIFE PHARMS INC by Nouveau Life Pharmaceuticals, Inc. (NOUV) competitors?

There are no as such competitors for NOUVEAU LIFE PHARMS INC by Nouveau Life Pharmaceuticals, Inc..

What is the forecast, or price target, for NOUVEAU LIFE PHARMS INC by Nouveau Life Pharmaceuticals, Inc. (NOUV) stock?

There is no analysis for NOUVEAU LIFE PHARMS INC by Nouveau Life Pharmaceuticals, Inc. to provide a consensus price target.

What is the current price for NOUVEAU LIFE PHARMS INC by Nouveau Life Pharmaceuticals, Inc. (NOUV)?

The stock price for NOUVEAU LIFE PHARMS INC by Nouveau Life Pharmaceuticals, Inc. (OTCEM: NOUV) is $0.000001 last updated May 27, 2026 at 9:30 AM EDT.

Does NOUVEAU LIFE PHARMS INC by Nouveau Life Pharmaceuticals, Inc. (NOUV) pay a dividend?

There are no upcoming dividends for NOUVEAU LIFE PHARMS INC by Nouveau Life Pharmaceuticals, Inc..

When is NOUVEAU LIFE PHARMS INC by Nouveau Life Pharmaceuticals, Inc. (OTCEM:NOUV) reporting earnings?

NOUVEAU LIFE PHARMS INC by Nouveau Life Pharmaceuticals, Inc. does not have any upcoming earnings scheduled.

Is NOUVEAU LIFE PHARMS INC by Nouveau Life Pharmaceuticals, Inc. (NOUV) going to split?

There is no upcoming split for NOUVEAU LIFE PHARMS INC by Nouveau Life Pharmaceuticals, Inc..

What sector and industry does NOUVEAU LIFE PHARMS INC by Nouveau Life Pharmaceuticals, Inc. (NOUV) operate in?

NOUVEAU LIFE PHARMS INC by Nouveau Life Pharmaceuticals, Inc. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCEM.